Atossa Therapeutics Announces the Appointment of Eric Van Zanten as Vice President, Investor and Public Relations

December 7, 2022

https://www.globenewswire.com/news-release/2022/12/07/2569221/0/en/Atossa-Therapeutics-Announces-the-Appointment-of-Eric-Van-Zanten-as-Vice-President-Investor-and-Public-Relations.html

SEATTLE, Dec. 07, 2022 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology, is pleased to announce the appointment of Eric Van Zanten as Vice President of Investor and Public Relations. Mr. Van Zanten brings over 25 years of corporate communications experience working within the biopharmaceutical, finance, and healthcare industries. He will oversee corporate, executive, and digital communications, investor relations, thought leadership, and branding for the Company.

Read more at globenewswire.com

Related news for (ATOS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.